FDA Inspection
LifeShare Blood CenterLifeShare Blood Center – FDA Inspection, Mar 10, 2023
Record Details
This FDA Inspection record concerns LifeShare Blood Center, with an inspection on March 10, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · c663f555-f0f3-4c3d-9a7d-2c96637aeb8c
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1201009
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of LifeShare Blood Center
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 19, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 26, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 10, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 21, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 3, 2009 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for LifeShare Blood Center
- FDA Inspection 1112129 - 2019-11-19
- FDA Inspection 1022399 - 2017-07-26
- FDA Inspection 887057 - 2014-07-10
- FDA Inspection 759971 - 2011-12-21
- FDA Inspection 628310 - 2009-11-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.